Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also sells its products online. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.
Industry, Sector and Symbol
Industry Industrial inorganic chemicals, not elsewhere classified
Sub-IndustryN/A
SectorMedical
WebN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
OptionableNot Optionable
ABCAM PLC/ADR (OTCMKTS:ABCZY) Frequently Asked Questions
What is ABCAM PLC/ADR's stock symbol?
ABCAM PLC/ADR trades on the OTCMKTS under the ticker symbol "ABCZY."
How often does ABCAM PLC/ADR pay dividends? What is the dividend yield for ABCAM PLC/ADR?
ABCAM PLC/ADR declared a Semi-Annual dividend on Tuesday, September 11th. Shareholders of record on Friday, November 9th will be paid a dividend of $0.091 per share on Friday, December 14th. The ex-dividend date is Thursday, November 8th. This is a boost from ABCAM PLC/ADR's previous Semi-Annual dividend of $0.04. View ABCAM PLC/ADR's Dividend History.
Has ABCAM PLC/ADR been receiving favorable news coverage?
Media headlines about ABCZY stock have trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ABCAM PLC/ADR earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days.
Who are some of ABCAM PLC/ADR's key competitors?
Some companies that are related to ABCAM PLC/ADR include ResMed (RMD), WellCare Health Plans (WCG), Merck KGaA (MKGAF), Cooper Companies (COO), GRIFOLS S A/S (GRFS), Hologic (HOLX), DexCom (DXCM), Teleflex (TFX), SYSMEX CORP/ADR (SSMXY), Sunny Optical Technology (Group) (SNPTF), Universal Health Services (UHS), SONOVA HLDG AG/ADR (SONVY), Varian Medical Systems (VAR), Quest Diagnostics (DGX) and Bausch Health Companies (BHC).
Who are ABCAM PLC/ADR's key executives?
ABCAM PLC/ADR's management team includes the folowing people:
- Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 51)
- Dr. Jonathan Simon Milner, Co-Founder & Non-Exec. Deputy Chairman (Age 54)
- Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 49)
- James Staveley, VP of Investor Relations
- Ms. Suzanne E. Smith LLB (Hons), MBA, Chief Legal Officer & Company Sec.
How do I buy shares of ABCAM PLC/ADR?
Shares of ABCZY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ABCAM PLC/ADR's stock price today?
One share of ABCZY stock can currently be purchased for approximately $17.56.
How big of a company is ABCAM PLC/ADR?
ABCAM PLC/ADR has a market capitalization of $3.60 billion.
MarketBeat Community Rating for ABCAM PLC/ADR (OTCMKTS ABCZY)
MarketBeat's community ratings are surveys of what our community members think about ABCAM PLC/ADR and other stocks. Vote "Outperform" if you believe ABCZY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABCZY will underperform the S&P 500 over the long term. You may vote once every thirty days.
